We speculate that DHA might inhibit CD4+ T-cell function by downregulating HIF-1 signaling pathways through HIF1a (HIF1α), potentially contributing to its therapeutic effects in lupus. The gene discussed is HIF1A; the disease is systemic lupus erythematosus.